Bulk Clinical Supply · Wharton's Jelly
EXO-W
A quantified exosome signalling platform for next-generation regenerative dermatology and trichology protocols. Supplied in bulk, direct to clinics.
One vial, engineered for consistency.
Every EXO-W vial is manufactured and quantified to the same specification, giving clinics a consistent, documented starting point for protocol planning.
Derivation
Umbilical cord Wharton's jelly — mesenchymal stem cell-derived exosomes.
Volume
1 ml per vial.
Form
Lyophilized (freeze-dried) powder.
Exosome Count
30 billion exosomes per vial.
Culture Conditions
Serum-free medium; no antibiotics or preservatives added.
Manufacturing Site
Certified Cell Processing Center (CPC), Japan — Class 100 cleanroom.
Regulatory Framework
Manufactured in compliance with Japan's Pharmaceutical and Medical Device Act (PMD Act) and applicable GMP standards.
Storage
Store as a lyophilized powder under recommended cold-chain conditions; reconstitute immediately before clinical use.
A dense, quantified signalling profile.
EXO-W's conditioned media is measured for its content of growth factors and cytokines, the signalling molecules associated with regeneration and repair.
IGF-2
Insulin-Like Growth Factor 2
IGFBP-2
IGF-Binding Protein 2
IGF-1
Insulin-Like Growth Factor 1
HGF
Hepatocyte Growth Factor
EGF
Epidermal Growth Factor
KGF
Keratinocyte Growth Factor
The full quantified bioactive profile, including pg/mL concentrations for every measured marker, donor screening standards, and batch release testing, is available in Hakke's clinical dossier. Request the clinical dossier